Intellectual Property India Publishes Patent Application for Substituted N-(4-Trifluoromethyl)-2-Cyanocrotonamide Compound, Preparation Method Therefor, And Pharmaceutical Composition And Use Thereof

MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617085066 A) filed by Tianjin Gudui Bio-Pharm Co. , Ltd. on July 10, 2026, for Substituted N-(4-Trifluoromethyl)-2-Cyanocrotonamide Compound, Preparation Method Therefor, And Pharmaceutical Composition And Use Thereof.

Inventors include Gao, Qingzhi; Liu, Shengnan; Gao, Xiangqian; Han, Jianbin; Zhang, Shunjie; Zhao, Fuping; Han, Xu; Zhu, Xiaoling; and Liu, Yang.

The application for the patent was published on September 04, 2026, under issue no. 36/2026.

Abstract: An N-(4-trifluoromethyl)-2-cyanocrotonamide compound, a preparation method therefor, and a pharmaceutical composition and use thereof. The compound of the present invention has a more significant treatment effect on central nervous system diseases such as multiple sclerosis and neuromyelitis optica.

Disclaimer: Curated by HT Syndication.